878 related articles for article (PubMed ID: 19356935)
1. Guillain-Barré syndrome: an update.
Vucic S; Kiernan MC; Cornblath DR
J Clin Neurosci; 2009 Jun; 16(6):733-41. PubMed ID: 19356935
[TBL] [Abstract][Full Text] [Related]
2. Axonal Guillain-Barré syndrome: concepts and controversies.
Kuwabara S; Yuki N
Lancet Neurol; 2013 Dec; 12(12):1180-8. PubMed ID: 24229616
[TBL] [Abstract][Full Text] [Related]
3. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
[TBL] [Abstract][Full Text] [Related]
4. The Guillain-Barré syndrome.
Fujimura H
Handb Clin Neurol; 2013; 115():383-402. PubMed ID: 23931791
[TBL] [Abstract][Full Text] [Related]
5. [Guillain Barré syndrome in pediatrics].
Erazo Torricelli R
Medicina (B Aires); 2009; 69(1 Pt 1):84-91. PubMed ID: 19240005
[TBL] [Abstract][Full Text] [Related]
6. Patterns of Guillain-Barre syndrome in children: results from a Mexican population.
Nachamkin I; Arzarte Barbosa P; Ung H; Lobato C; Gonzalez Rivera A; Rodriguez P; Garcia Briseno A; Cordero LM; Garcia Perea L; Perez JC; Ribera M; Aldama PC; Guitérrez GD; Sarnat LF; García MR; Veitch J; Fitzgerald C; Cornblath DR; Rodriguez Pinto M; Griffin JW; Willison HJ; Asbury AK; McKhann GM
Neurology; 2007 Oct; 69(17):1665-71. PubMed ID: 17898327
[TBL] [Abstract][Full Text] [Related]
7. Nodal proteins are target antigens in Guillain-Barré syndrome.
Devaux JJ; Odaka M; Yuki N
J Peripher Nerv Syst; 2012 Mar; 17(1):62-71. PubMed ID: 22462667
[TBL] [Abstract][Full Text] [Related]
8. Guillain-Barré Syndrome.
Kaida K
Adv Exp Med Biol; 2019; 1190():323-331. PubMed ID: 31760653
[TBL] [Abstract][Full Text] [Related]
9. Guillain-Barré syndrome.
Arcila-Londono X; Lewis RA
Semin Neurol; 2012 Jul; 32(3):179-86. PubMed ID: 23117942
[TBL] [Abstract][Full Text] [Related]
10. Clinical, electrophysiological subtypes and antiganglioside antibodies in childhood Guillain-Barré syndrome.
Kannan MA; Ch RK; Jabeen SA; Mridula KR; Rao P; Borgohain R
Neurol India; 2011; 59(5):727-32. PubMed ID: 22019659
[TBL] [Abstract][Full Text] [Related]
11. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome.
Kuwabara S; Yuki N; Koga M; Hattori T; Matsuura D; Miyake M; Noda M
Ann Neurol; 1998 Aug; 44(2):202-8. PubMed ID: 9708542
[TBL] [Abstract][Full Text] [Related]
12. Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain-Barré syndrome.
Hiraga A; Kuwabara S; Ogawara K; Misawa S; Kanesaka T; Koga M; Yuki N; Hattori T; Mori M
Neurology; 2005 Mar; 64(5):856-60. PubMed ID: 15753422
[TBL] [Abstract][Full Text] [Related]
13. Antiganglioside antibodies in Guillain-Barré syndrome and its related conditions.
Shahrizaila N; Yuki N
Expert Rev Neurother; 2011 Sep; 11(9):1305-13. PubMed ID: 21864076
[TBL] [Abstract][Full Text] [Related]
14. Guillain-Barré syndrome.
Hughes RA; Cornblath DR
Lancet; 2005 Nov; 366(9497):1653-66. PubMed ID: 16271648
[TBL] [Abstract][Full Text] [Related]
15. Axonal Guillain-Barré syndrome: carbohydrate mimicry and pathophysiology.
Yuki N; Kuwabara S
J Peripher Nerv Syst; 2007 Dec; 12(4):238-49. PubMed ID: 18042134
[TBL] [Abstract][Full Text] [Related]
16. Antiglycolipid antibodies in Guillain-Barré syndrome and related diseases: review of clinical features and antibody specificities.
Ariga T; Yu RK
J Neurosci Res; 2005 Apr; 80(1):1-17. PubMed ID: 15668908
[TBL] [Abstract][Full Text] [Related]
17. Electrodiagnostic criteria for Guillain-Barrè syndrome: a critical revision and the need for an update.
Uncini A; Kuwabara S
Clin Neurophysiol; 2012 Aug; 123(8):1487-95. PubMed ID: 22480600
[TBL] [Abstract][Full Text] [Related]
18. [Guillain-Barré syndrome: clinical features, immune mechanisms, and therapies].
Nomura K
Rinsho Shinkeigaku; 1996 Dec; 36(12):1367-9. PubMed ID: 9128414
[TBL] [Abstract][Full Text] [Related]
19. Clinical features and response to treatment in Guillain-Barré syndrome associated with antibodies to GM1b ganglioside.
Yuki N; Ang CW; Koga M; Jacobs BC; van Doorn PA; Hirata K; van der Meché FG
Ann Neurol; 2000 Mar; 47(3):314-21. PubMed ID: 10716250
[TBL] [Abstract][Full Text] [Related]
20. The immunobiology of Guillain-Barré syndromes.
Willison HJ
J Peripher Nerv Syst; 2005 Jun; 10(2):94-112. PubMed ID: 15958123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
